Literature DB >> 22205899

Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.

George Saraci1, Anamaria Treta.   

Abstract

Basedow-Graves disease is an autoimmune condition with multiple local and systemic aspects. Among these, oculopathy has a major impact on patient's life from both functional and esthetic point of view. Basedow-Graves oculopathy requires an appropriate positive and differential diagnosis using clinical and imagistic approaches. Treatment is always required in moderate or severe forms and it begins with simple general points and continues with medical and surgical therapies. Current article stresses upon the most characteristic clinical signs of thyroidian ophthalmopathy and the required current therapeutic approaches.

Entities:  

Keywords:  Basedow-Graves disease; exophtalmic goitre; thyroidian ophthalmopathy

Year:  2011        PMID: 22205899      PMCID: PMC3239395     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  39 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

Review 2.  Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.

Authors:  Hadas Stiebel-Kalish; Eyal Robenshtok; Murat Hasanreisoglu; David Ezrachi; Ilan Shimon; Leonard Leibovici
Journal:  J Clin Endocrinol Metab       Date:  2009-06-02       Impact factor: 5.958

3.  Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study.

Authors:  Graziano Ceresini; Fulvio Lauretani; Marcello Maggio; Gian Paolo Ceda; Simonetta Morganti; Elisa Usberti; Carlo Chezzi; Rita Valcavi; Stefania Bandinelli; Jack M Guralnik; Anne R Cappola; Giorgio Valenti; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2008-11-19       Impact factor: 5.562

4.  Thyroid eye disease.

Authors:  Petros Perros; Christopher Neoh; Jane Dickinson
Journal:  BMJ       Date:  2009-03-06

5.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

6.  Treatment of Graves' hyperthyroidism--prognostic factors for outcome.

Authors:  Assim Alfadda; Usman H Malabu; Mahmoud I El-Desouki; Khalid A Al-Rubeaan; Atallah D Al-Ruhaily; Mona A Fouda; Mohamed A Al-Maatouq; Riad A Sulimani
Journal:  Saudi Med J       Date:  2007-02       Impact factor: 1.484

7.  Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy.

Authors:  Guy J Ben Simon; Ahmad M Mansury; Robert M Schwarcz; Seongmu Lee; John D McCann; Robert A Goldberg
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

Review 8.  Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.

Authors:  Christopher I Zoumalan; Kimberly P Cockerham; Roger E Turbin; Nicholas J Volpe; Michael Kazim; Raymond S Douglas; Steven E Feldon
Journal:  J Neuroophthalmol       Date:  2007-09       Impact factor: 3.042

Review 9.  Quality of life in patients with benign thyroid disorders. A review.

Authors:  Torquil Watt; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

10.  Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis.

Authors:  Davide Nacamulli; Caterina Mian; Daniela Petricca; Francesca Lazzarotto; Susi Barollo; Dina Pozza; Stefano Masiero; Diego Faggian; Mario Plebani; Maria E Girelli; Franco Mantero; Corrado Betterle
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

View more
  3 in total

Review 1.  Ocular surface disease in thyroid eye disease: A narrative review.

Authors:  Harkaran S Rana; Sruti S Akella; Carson E Clabeaux; Zachary P Skurski; Vinay K Aakalu
Journal:  Ocul Surf       Date:  2022-02-12       Impact factor: 6.268

Review 2.  Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.

Authors:  Natacha Turck; Simone Eperon; Maria De Los Angeles Gracia; Aurélie Obéric; Mehrad Hamédani
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

3.  Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome).

Authors:  Samuel Dagogo-Jack
Journal:  Diabetes Care       Date:  2015-12       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.